These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. [Anatomico-pathological observations of the peculiarities of lung carcinoma-polymorphism, paradoxes and exaggerations]. FROBOESE C Z Gesamte Inn Med; 1951 Jun; 6(11-12):321-30. PubMed ID: 14856152 [No Abstract] [Full Text] [Related]
46. Comparing mindfulness based cognitive therapy and traditional cognitive behavior therapy with treatments as usual on reduction of major depressive disorder symptoms. Omidi A; Mohammadkhani P; Mohammadi A; Zargar F Iran Red Crescent Med J; 2013 Feb; 15(2):142-6. PubMed ID: 23682326 [TBL] [Abstract][Full Text] [Related]
47. Debrisoquine hydroxylation phenotype, acetylation phenotype, and ABO blood groups as genetic host factors of lung cancer risk. Roots I; Drakoulis N; Ploch M; Heinemeyer G; Loddenkemper R; Minks T; Nitz M; Otte F; Koch M Klin Wochenschr; 1988; 66 Suppl 11():87-97. PubMed ID: 2846954 [TBL] [Abstract][Full Text] [Related]
48. Acetylator phenotype in patients with lung carcinoma--a negative report. Burgess EJ; Trafford JA Eur J Respir Dis; 1985 Jul; 67(1):17-9. PubMed ID: 4054252 [TBL] [Abstract][Full Text] [Related]
49. Genetic polymorphism of N-acetyltransferase 2 in patients with esophageal cancer. Shibuta J; Eto T; Kataoka A; Inoue H; Ueo H; Suzuki T; Barnard GF; Mori M Am J Gastroenterol; 2001 Dec; 96(12):3419-24. PubMed ID: 11774959 [TBL] [Abstract][Full Text] [Related]
50. Acetylation pharmacogenetics. The slow acetylator phenotype is caused by decreased or absent arylamine N-acetyltransferase in human liver. Grant DM; Mörike K; Eichelbaum M; Meyer UA J Clin Invest; 1990 Mar; 85(3):968-72. PubMed ID: 2312737 [TBL] [Abstract][Full Text] [Related]
51. N-acetylation polymorphism in patients with lung cancer and its association with p53 gene mutation. Oyama T; Kawamoto T; Mizoue T; Yasumoto K; Kodama Y; Mitsudomi T Anticancer Res; 1997; 17(1B):577-81. PubMed ID: 9066583 [TBL] [Abstract][Full Text] [Related]
52. [Acetylation polymorphism in lung cancer]. Laredo Quesada JM; Jara Sánchez C; Benítez Rodríguez J; Fernández Gundín MJ; Vargas Castrillón E; Muñoz González JJ; Llerena Ruiz A; Cobaleda Polo J; Pérez-Manga G An Med Interna; 1991 Feb; 8(2):66-8. PubMed ID: 1893005 [TBL] [Abstract][Full Text] [Related]